MedTrace Logo

MRI T1 Relaxation Time in Rectal Cancer

NCT05876026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-01-07

No results posted yet for this study

Summary

The goal of this observational study is to learn about the T1 relaxation time and T1 relaxation time properties of the disease in people with locally advanced rectal cancer. The main question it aims to answer is:

Does MRI T1 relaxation time have a high diagnostic performance in recognizing fibrosis as a complete response to neoadjuvant treatment of rectal cancer?

Participants will receive standard neoadjuvant treatment and be part of the standard examination programme regarding rectal cancer.

Conditions

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Søren Rafaelsen, DMSc · Vejle Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-08
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876026 on ClinicalTrials.gov